Early virus clearance of SARS-CoV-2 among co-infection with malaria
- PMID: 37417172
- DOI: 10.4103/0972-9062.364758
Early virus clearance of SARS-CoV-2 among co-infection with malaria
Abstract
Background and objectives: India has witnessed significant number of cases of co-infection of malaria or dengue with COVID-19, especially during the monsoon season. It has been speculated that anti-malarial immunity might have a protective role in co-infection. Retrospective analysis of co-infection of vector-borne diseases with COVID-19 was done for comparing their remission with matched controls with COVID-19 by means of epidemiological data.
Methods: Medical case records of patients with co-infection of malaria or dengue with COVID-19 admitted at TNMC and BYL Nair Charitable Hospital from 1 March 2020 to 31 October 2020 were analyzed retrospectively. Out of 91 cases of co-infection of SARS-CoV-2 infection with vector-borne diseases, virus clearance (VC) analysis was done for 61 co-infections with malaria.
Results: Median duration of VC for co-infection with malaria was 8 days whereas, it was 12 days for controls with COVID-19 (p=0.056). Young patients (≤50 years) with co-infection recovered faster than controls age (p=0.018).
Interpretation & conclusion: Co-infection with malaria is associated with less severe disease and early recovery in the form of early VC. Genetic and immunological studies are necessary to confirm malaria protection against SARS-CoV-2 infection.
Keywords: COVID-19; SARS-CoV-2 infection; co-infection; dengue; malaria; vector-borne disease.
Similar articles
-
Co-infection of malaria and early clearance of SARS-CoV-2 in healthcare workers.J Med Virol. 2021 Apr;93(4):2431-2438. doi: 10.1002/jmv.26760. Epub 2021 Jan 5. J Med Virol. 2021. PMID: 33368412
-
Coinfection between SARS-CoV-2 and vector-borne diseases in Luanda, Angola.J Med Virol. 2022 Jan;94(1):366-371. doi: 10.1002/jmv.27354. Epub 2021 Sep 27. J Med Virol. 2022. PMID: 34546584 Free PMC article.
-
Co-infection of SARS-CoV-2 with Malaria or Dengue in 91 Patients at a First Dedicated COVID-19 Hospital in India.J Assoc Physicians India. 2021 Jun;69(6):11-12. J Assoc Physicians India. 2021. PMID: 34472798 No abstract available.
-
SARS-CoV-2 and dengue virus co-infection: Epidemiology, pathogenesis, diagnosis, treatment, and management.Rev Med Virol. 2023 Jan;33(1):e2340. doi: 10.1002/rmv.2340. Epub 2022 Mar 3. Rev Med Virol. 2023. PMID: 35238422 Free PMC article. Review.
-
Coinfection of COVID-19 and malaria: clinical profiles, interactions, and strategies for effective control.Malar J. 2025 Mar 25;24(1):99. doi: 10.1186/s12936-025-05315-8. Malar J. 2025. PMID: 40133914 Free PMC article. Review.
Cited by
-
SARS-CoV-2 decreases malaria severity in co-infected rodent models.Front Cell Infect Microbiol. 2023 Dec 13;13:1307553. doi: 10.3389/fcimb.2023.1307553. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 38156320 Free PMC article.
-
Impacts of COVID-19 on malaria elimination strategies in Asia: A scoping review.Narra J. 2024 Dec;4(3):e1492. doi: 10.52225/narra.v4i3.1492. Epub 2024 Nov 25. Narra J. 2024. PMID: 39816106 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous